calendar
32,057 catalysts · 12,554 approval · 5,000 device 510k · 4,728 grant · 2,984 8k filing · 2,000 device pma · 2,000 device recall
next 91 dayslessmore
MonWedFri
32,057 catalysts · 12,554 approval · 5,000 device 510k · 4,728 grant · 2,984 8k filing · 2,000 device pma · 2,000 device recall
Sponsor: PFIZER. Form: TABLET. Route: ORAL
Sponsor: PFIZER. Form: TABLET. Route: ORAL
Sponsor: NOVO NORDISK INC. Form: SOLUTION. Route: SUBCUTANEOUS
Sponsor: HISAMITSU PHARM CO. Form: PATCH. Route: TOPICAL
Sponsor: ABBVIE. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL
Sponsor: BIONPHARMA. Form: CAPSULE, DELAYED RELEASE. Route: ORAL
Sponsor: ABBVIE. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: ABBVIE. Form: TABLET, DELAYED RELEASE. Route: ORAL
Sponsor: PFIZER. Form: TABLET. Route: ORAL
Sponsor: TAKEDA PHARMS USA. Form: CAPSULE. Route: ORAL
Sponsor: TAKEDA PHARMS USA. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL
Sponsor: HIKMA. Form: TABLET. Route: ORAL
Sponsor: TAKEDA PHARMS USA. Form: TABLET. Route: ORAL
Sponsor: ACTELION. Form: TABLET. Route: ORAL
Sponsor: FRESENIUS KABI USA. Form: INJECTABLE. Route: INJECTION
Sponsor: AUROLIFE PHARMA LLC. Form: TABLET. Route: ORAL
Sponsor: TERSERA. Form: IMPLANT. Route: IMPLANTATION
Sponsor: TERSERA. Form: IMPLANT. Route: IMPLANTATION
Sponsor: TERSERA. Form: IMPLANT. Route: IMPLANTATION
Sponsor: TERSERA. Form: IMPLANT. Route: IMPLANTATION
Sponsor: VERITY. Form: INJECTABLE. Route: INTRAMUSCULAR
Sponsor: ENDO OPERATIONS. Form: IMPLANT. Route: SUBCUTANEOUS
Sponsor: HOSPIRA INC. Form: INJECTABLE. Route: INJECTION
Sponsor: PFIZER. Form: INJECTABLE. Route: INJECTION
Sponsor: MYLAN INSTITUTIONAL. Form: INJECTABLE. Route: INJECTION
Sponsor: CHARTWELL MOLECULAR. Form: SOLUTION. Route: ORAL
Sponsor: CHARTWELL MOLECULAR. Form: SOLUTION. Route: ORAL
Sponsor: EUROFARMA. Form: SUSPENSION. Route: TOPICAL
Sponsor: EUROFARMA. Form: CREAM. Route: TOPICAL
Sponsor: PHARM ASSOC. Form: SOLUTION. Route: ORAL
Sponsor: GLAND PHARMA LTD. Form: INJECTABLE. Route: INJECTION
Sponsor: GLAND PHARMA LTD. Form: INJECTABLE. Route: INJECTION
Sponsor: GLAND PHARMA LTD. Form: INJECTABLE. Route: INJECTION
Sponsor: GLAND PHARMA LTD. Form: INJECTABLE. Route: INJECTION
Sponsor: GENENTECH. Form: INJECTABLE. Route: INJECTION
Sponsor: GENZYME CORP. Form: TABLET. Route: ORAL
Sponsor: RISING. Form: INJECTABLE. Route: INJECTION
Sponsor: EDENBRIDGE PHARMS. Form: TABLET. Route: SUBLINGUAL
Sponsor: RHODES PHARMS. Form: TABLET. Route: ORAL
Sponsor: CHARTWELL MOLECULAR. Form: SOLUTION. Route: ORAL
Sponsor: ACTAVIS ELIZABETH. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: PH HEALTH. Form: TABLET. Route: ORAL
Sponsor: COLLEGIUM PHARM INC. Form: TABLET. Route: ORAL
Sponsor: COLLEGIUM PHARM INC. Form: TABLET. Route: ORAL
Sponsor: COLLEGIUM PHARM INC. Form: TABLET. Route: ORAL
Sponsor: COLLEGIUM PHARM INC. Form: TABLET. Route: ORAL
Sponsor: COLLEGIUM PHARM INC. Form: TABLET. Route: ORAL
Sponsor: PH HEALTH. Form: TABLET. Route: ORAL
Sponsor: HIKMA. Form: SOLUTION. Route: ORAL
Sponsor: HIKMA. Form: TABLET, EXTENDED RELEASE. Route: ORAL